 |
crenolanib besylate |
|---|---|
| Trade Name | |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2010-12-20 00:00:00 |
| Sponsor | AROG Pharmaceuticals, LLC;Two Lincoln Centre, Suite 410;Dallas, Texas, 75240 |
Related Access Program
| |
crenolanib besylate |
|---|---|
| Trade Name | |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2010-12-20 00:00:00 |
| Sponsor | AROG Pharmaceuticals, LLC;Two Lincoln Centre, Suite 410;Dallas, Texas, 75240 |